Holeman I, Evans J, Kane D, Grant L, Pagliari C, Weller D
Judge Business School, University of Cambridge, UK; Global Health Academy, University of Edinburgh, UK; Medic Mobile, San Francisco, California, USA.
Eur J Cancer Care (Engl). 2014 Nov;23(6):750-6. doi: 10.1111/ecc.12250. Epub 2014 Oct 17.
Many current global health opportunities have less to do with new biomedical knowledge than with the coordination and delivery of care. While basic research remains vital, the growing cancer epidemic in countries of low and middle income warrants urgent action - focusing on both research and service delivery innovation. Mobile technology can reduce costs, improve access to health services, and strengthen health systems to meet the interrelated challenges of cancer and other noncommunicable diseases. Experience has shown that even very poor and remote communities that only have basic primary health care can benefit from mobile health (or 'mHealth') interventions. We argue that cancer researchers and practitioners have an opportunity to leverage mHealth technologies that have successfully targeted other health conditions, rather than reinventing these tools. We call for particular attention to human centred design approaches for adapting existing technologies to suit distinctive aspects of cancer care and to align delivery with local context - and we make a number of recommendations for integrating mHealth delivery research with the work of designers, engineers and implementers in large-scale delivery programmes.
当前许多全球卫生机遇与新的生物医学知识关联不大，而更多地涉及医疗服务的协调与提供。虽然基础研究仍然至关重要，但低收入和中等收入国家日益严重的癌症流行情况需要采取紧急行动——既要关注研究，也要注重服务提供方面的创新。移动技术可以降低成本、改善卫生服务的可及性，并加强卫生系统，以应对癌症和其他非传染性疾病的相关挑战。经验表明，即使是仅有基本初级卫生保健的非常贫困和偏远社区，也能从移动健康（或“mHealth”）干预措施中受益。我们认为，癌症研究人员和从业者有机会利用已成功应用于其他健康状况的移动健康技术，而不是重新发明这些工具。我们呼吁特别关注以人为本的设计方法，以使现有技术适应癌症护理的独特方面，并使服务提供与当地情况相匹配——我们还就将移动健康服务研究与设计师、工程师以及大规模服务项目实施者的工作相结合提出了一些建议。
